OCP Pretreatment in PCOS Patients Undergoing ICSI Using Antagonist Protocol

Summary

373 women with PCOS undergoing a trial of IVF/ICSI will receive OCP from day 2 of the preceding cycle for 21 days followed by GnRH antagonist COH. Another 373 women with PCOS undergoing a trial of IVF/ICSI will start GnRH antagonist COH directly without OCP pretreatment. Both groups will be followed up for effect on ongoing pregnancy rate.

Timeline

Start

2017-06-01

Primary completion

2019-07-01

Completion

2019-07-01

Drugs

Indications